Checkpoint Inhibitor Refractory Cancer Market Set for Remarkable Growth by 2032

New York, Wednesday, 19 November 2025.
The global market for checkpoint inhibitor refractory cancer is predicted to grow significantly from 2024 to 2031, driven by innovations in oncology and increasing investment in targeted therapies.